Chemerin, leptin and psoriasin are pro-inflammatory and immunemodulatory proteins associated with psoriasis and displayed higher circulating levels. Their relation to atherosclerosis in psoriatic patients has been investigated in numerous studies with wide-ranging results. Therefore, the present study aimed to assess plasma levels of chemerin, leptin and psoriasin and evaluate their relationship with carotid intima-media thickness (CIMT) and epicardial fat thickness (EFT) as potential predictors for subclinical atherosclerosis in psoriasis patients. The study included fifty psoriatic patients and forty age and gender matched healthy controls. Clinical severity of psoriasis was evaluated by Psoriasis Area and Severity Index (PASI). Fasting blood glucose and lipid profile were estimated. Plasma levels of high sensitivity-CRP (hs-CRP), chemerin, leptin and psoriasin were measured by ELISA. CIMT and EFT were assessed by Ultrasonography and Echocardiography, respectively. Plasma levels of hs-CRP, chemerin, leptin and psoriasin as well as CIMT and EFT were significantly elevated in psoriasis patients compared to controls. CIMT and EFT were significantly positively correlated with PASI, plasma hs-CRP, chemerin, leptin and psoriasin. Moreover, significant positive correlation was demonstrated between PASI and plasma hs-CRP, chemerin, leptin and psoriasin. Multiple linear regression analyses showed that chemerin, leptin and psoriasin were independently correlated with CIMT and EFT and exhibited high significance for predicting their values. It can be concluded that chemerin, leptin and psoriasin might represent an important link between psoriasis and atherosclerosis. Measurements of plasma chemerin, leptin and psoriasin along with CIMT and EFT seem to be valuable potential markers of subclinical atherosclerosis in patients with psoriasis.
INTRODUCTION
Psoriasis is a T-cell mediated, chronic inflammatory skin disease characterized by hyperproliferation of keratinocytes. It is recognized by the presence of erythematous, silvery scaly and well-defined plaques particularly over extremities and scalp (Hawkes et al., 2017).
It is the most predominant chronic inflammatory disorder in humans, affecting about 2-4% of the population worldwide (Michalek et al., 2017).
Psoriasis is currently prescribed as a multi-systemic inflammatory disorder rather than a disease of the skin and joints only. Atherosclerosis is one of the systemic involvements of psoriasis, where the inflammatory processes provide a major link between the two diseases. Persistent skin inflammation triggers a cascade of systemic inflammatory events resulting in premature atherosclerosis and increased risk of cardiovascular disease (CVD) in psoriasis patients (Dattilo et al., 2018) . Accordingly, psoriasis seems to be an independent risk factor for subclinical atherosclerosis and CVD even after adjusting for conventional risk factors such as smoking, hypertension, diabetes and obesity (Kolliker Frers et al., 2018) .
Chemerin is a novel adipokine mainly expressed in adipocytes of white adipose tissue. It is a chemo-attractant protein with inflammatory and immune-modulatory functions. It plays an essential role in cell differentiation, angiogenesis, lipid metabolism and insulinmediated pathways (Eichelmann et al., 2017). High circulating chemerin level and up-regulation of its gene were detected in a variety of chronic inflammatory conditions. It is highly expressed in psoriatic lesions, thus indicates its involvement in the disease pathogenesis by
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stimulating skin innate immunity and inducing chemotaxis (Banas et al., 2015) . Leptin is one of the classical adipokines that secreted mainly by adipose tissue. It regulates several metabolic pathways such as; appetite and body weight, glucose and lipid homeostasis and insulin sensitivity (Zhang and Chua, 2017) . It controls many cellular inflammatory cascades through production of pro-inflammatory cytokines, modulating T-helper cell activity and promoting keratinocyte proliferation, therefore its definite contribution in the pathogenesis of psoriasis (Kyriakou et al., 2017) .
Psoriasin (hS100A7) is a member of the multigenic S100 calciumbinding proteins family, expressed mainly by epithelial cells. Because of its role in calcium binding and signaling, it has involved in cellular proliferation, differentiation, apoptosis, inflammatory and immunemodulatory activity (Cunden et al., 2017). It was first recognized as an over-expressed protein in psoriatic lesions acting as proinflammatory mediator and chemo-attractant molecule for T-cells, hence its role in the disease pathogenesis (Ekman et al., 2017).
Carotid intima-media thickness (CIMT) is a non-invasive imaging tool, used to diagnose atherosclerotic process at its pre-occlusive stage i.e. subclinical atherosclerosis in high-risk individuals. Intimal smooth muscle proliferation and atherogenic aggregation may explain the increased CIMT and early-onset atherosclerosis in psoriasis patients (Santilli et al., 2016) . Epicardial fat thickness (EFT) is a metabolically active tissue that refers to cardiac adiposity and produces various atherogenic and inflammatory cytokines. It contributes to cellular infiltration, angiogenesis and endothelial dysfunction of the vascular intima, and consequently the development of atherosclerosis (Wang et al., 2016) . Therefore, our study aimed to measure the plasma levels of chemerin, leptin and psoriasin and evaluate their possible relationship with CIMT and EFT as potential predictors for subclinical atherosclerosis in psoriasis patients.
MATERIALS AND METHODS

Subjects:
This study was conducted at Medical Biochemistry, Dermatology, Diagnostic Radiology and Cardiology Departments, Faculty of Medicine, Menoufia University, Egypt, during the period from March to December 2017. A total number of (90) subjects were enrolled in Nevein M. Al-sheikh et all ‫ـــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ‬ ‫ـــ‬ ‫ــــــــــــــ‬ ‫ــــــــــــــــــــــــــــــ‬ ‫ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ‬ 20 the study and classified into two groups. Group (1): included (50) patients with chronic plaque psoriasis (their ages ranged from 36-54 years), were recruited from dermatology outpatient clinic. Group (2): included (40) age-and gender-matched healthy controls (their ages ranged from 37-52 years), with negative family history of psoriasis. Written consents were obtained from all subjects after approval of the study protocol by the Human Rights in Research Committee at Menoufia University.
Psoriasis patients were clinically assessed using Psoriasis Area and Severity Index (PASI) Score. Both intensity and extent of psoriatic plaques were calculated for 4 anatomical regions (head, arms, trunk and legs) by a physician who specified: (i) the percent of area of skin involved and (ii) the severity of three clinical signs; erythema, induration and desquamation on a scale from 0 to 4 indicating; no involvement, slight, moderate, severe and very severe, respectively. The patients were categorized according to their PASI score as mild (<10); moderate (10-14) and severe psoriasis (>14) (Kothiwala et al., 2016). All subjects of the study were submitted to complete history taking, overall clinical examinations, blood pressure assessment and anthropometric measurements. Body mass index (BMI) was calculated as [wt (kg) / height (m) 2 ] (Janssen, 2013). For Waist/ Hip Ratio (WHR), waist circumference was measured between the lowest rib and iliac crest and hip circumference was taken at the widest area of the hips at the greatest protuberance of the buttocks. The waist measurement was then divided by the hip measurement (Rashiti et al., 2017) . Exclusion criteria were: patients < 18 or > 60 years; smoking; BMI >35 kg/m 2 ; history of CVD, DM, hypertension, dyslipidemia; pregnant and lactating females and the use of retinoid therapy 6 months prior to study enrolment.
Blood Sampling:
After 12 hours of an overnight fasting, 10 ml of venous blood were collected from all subjects and distributed as follow: One ml into sodium flouride tube for blood glucose estimation; 5 ml into EDTA tube and 4 ml into a plain tube allowed to clot at room temperature. Both EDTA and plain tubes were centrifuged at 4000 r.p.m for 10 minutes, and the supernatant serum and plasma were separated and stored at -80°C until further analysis. -Plasma Psoriasin was measured using (Psoriasin ELISA Kit, CircuLex, Nagano, Japan). The detection range for the assay was 0.12-90 ng/mL (Awad et al., 2018).
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-Carotid Intima-Media Thickness (CIMT) was measured using BMode Ultrasonography (Aplio 400 Ultrasound, Toshiba, Japan). It was performed bilaterally, 1 cm proximal to the carotid bulb in a longitudinal view and calculated as the arithmetic mean of right and left carotid arteries measurements. CIMT value of 1.0 mm was considered as cut-off point for a significant intima-media thickness, predicting subclinical atherosclerosis (Awad et al., 2018).
--Epicardial Fat Thickness (EFT) was measured using Transthoracic Echocardiography (Vivid 9, General Electric, Norway). It was calculated as the mean value of the measurements at end-diastole in three cardiac cycles. EFT value of 6.3 mm was taken as a cut-off point, indicating subclinical atherosclerosis (Cetin et al., 2013) .
[Statistical Analysis: Data were statistically analyzed using SPSS version 20 (SPSS Inc., Chicago, Illinois, USA). Quantitative data were expressed as mean ± standard deviation and qualitative data were expressed as percentage.
Normally distributed quantitative data were tested using independent Nevein M. Al-sheikh et all ‫ـــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ‬ ‫ـــ‬ ‫ــــــــــــــ‬ ‫ــــــــــــــــــــــــــــــ‬ ‫ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ‬ 22 t-test. Chi square test (χ2) was used to verify the association between qualitative variables. Pearson's correlation coefficients (r) were calculated to assess the relation of PASI Score, CIMT and EFT with other studied risk variables. A Multiple linear regression analysis was constructed to evaluate the impact of independent variables (predictors) on dependant variables (CIMT & EFT). P-values at < 0.05 were considered statistically significant.
[[
RESULTS
The present study included; 50 patients with psoriasis as Group (1), they were 23 males and 27 females with mean age of 45.3± 6.5 years; and 40 age and gender matched healthy controls as Group (2), they were 20 males and 20 females with mean age of 44.5± 5.9 years. No significant differences were demonstrated between psoriasis patients and controls regarding; age, gender, BMI, SBP, DBP or FBG (p>0.05). High statistically significant differences were identified between both groups as regard; WHR, TC, TGs, HDL-c, LDL-c and hs-CRP (p< 0.001). Plasma chemerin, leptin and psoriasin were significantly higher in psoriasis patients than in controls; (351.2± 68.2 vs. 210.6± 46.5), (41.4± 7.5 vs. 11.4± 3.2) and (56.3± 10.5 vs. 22.6± 5.4), respectively (p<0.001). CIMT and EFT were markedly elevated in psoriasis patients than in controls; (1.06± 0.31 vs. 0.62± 0.08),(6.8± 1.12 vs. 3.2± 0.52), respectively (p < 0.001) [ Table 1 ].
Pearson correlation analysis revealed that; PASI Score was positively correlated with WHR, TC, TGs, LDL-c, hs-CRP, chemerin, leptin, psoriasin, CIMT and EFT, while inversely correlated with HDL-c (p< 0.001). However, PASI did not show any correlation with age, gender, BMI, SBP, DBP or FBG (p>0.05) [ Table 2 ]. CIMT and EFT showed significant positive correlations with WHR, TC, TGs, LDL-c, hs-CRP, chemerin, leptin and psoriasin and significant inverse correlation with HDL-c (p<0.001). However, CIMT and EFT did not correlate with age, gender, BMI, SBP, DBP or FBG (p > 0.05) [ Table  3 ]. Multiple linear regression analysis with CIMT as a dependent variable showed that; hs-CRP, chemerin, leptin and psoriasin were independently correlated with CIMT. The highest significant predictor for CIMT was chemerin (β=0.004, T=3.24, P= 0.002), followed by psoriasin (β=0.029, T=3.05, P=0.004), then hs-CRP (β= 0.16, T=2.55, P= 0.01) and leptin (β=0.46, T=2.11, P=0.04) [ 
DISCUSSION
Psoriasis is the most prevalent chronic inflammatory disease of the skin and joints and associated with serious multi-systemic consequences. Psoriasis patients are at a higher risk to develop CVD, especially atherosclerosis due to the remarkable similarity of inflammatory pathways between psoriasis and atherosclerosis. Cardiovascular diseases are the commonest cause of death in patients with severe psoriasis, thus early detection of subclinical atherosclerosis might be beneficial in reducing cardiovascular morbidity and mortality (Dattilo et al., 2018) have recently focused on novel biomarkers that could aid in psoriasis diagnosis and predicting its co-morbid effects. Chemerin, leptin and psoriasin are pro-inflammatory, immune-modulatory molecules that have displayed higher systemic circulating levels, over-expression in psoriatic skin lesions as well as striking association with the disease severity and co-morbidities (Aksu et al., 2017; Kyriakou et al.,  2017; Awad et al., 2018) .
Several studies have demonstrated higher CIMT in psoriasis patients and independently from atherosclerotic risk factors, which indicate the strong relation between psoriasis and carotid atherosclerosis (Dinić et al., 2016; Santilli et al., 2016) . Furthermore, EFT showed greater values in psoriasis patients, being as a recent cardio-metabolic risk factor and contributing to the development of atherosclerosis (Wang et al., 2016) . Therefore, this study aimed to assess the plasma levels of chemerin, leptin and psoriasin and investigated their relation with CIMT and EFT as possible predictors for subclinical atherosclerosis in psoriasis patients.
In the current study; age, gender, BMI, blood pressure and blood glucose were matched in patients and controls to exclude their probable effects in estimating the studied atherogenic parameters. However, waist/hip ratio was significantly elevated in psoriatic patients than in controls, as well as it was positively correlated with the disease severity as indicated by PASI. The relation between psoriasis and obesity is assumed bidirectional, where psoriasis predisposes patients to obesity and obesity may be a risk factor for developing psoriasis. Abdominal adiposity is an active metabolic organ producing adipokines as leptin and chemerin. The aberrant production of these adipokines promotes the chronic inflammatory cascades in psoriasis. On the other hand, systemic inflammatory process in psoriasis especially in its severe state might cause weight gain and fat mass redistribution (El-Boghdady et al.,  2018) .
The present study revealed, higher levels of TC, TGs, and LDL-c and lower levels of HDL-c in patients compared to controls. Additionally TC, TGs, and LDL-c were directly correlated with the who reported significant dyslipidemia in psoriasis patients that was strongly associated with the disease duration and severity. Dyslipidemia is the most prevalent metabolic abnormality existing in psoriasis and correlate positively with the disease severity. Excess adiposity and pro-inflammatory activities induced by adipocytederived cytokines as leptin seem to have a crucial role in the excessive changes of lipids and lipoproteins. This inflammatory process and dyslipidemia in psoriasis especially its severe variants could explain the high risk of developing atherosclerosis (Furue et al., 2017) .
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In this study, hs-CRP was highly elevated in psoriasis patients versus controls and positively correlated with disease severity. ) who stated that, the cumulative effects of chemerin, leptin and psoriasin on CIMT and EFT denoting the significant correlation of cardiovascular risk factors and inflammatory biomarkers. In addition, high CIMT and EFT together with elevated plasma chemerin, leptin and psoriasin may exhibit synergistic effect to increase the risk of subclinical atherosclerosis in psoriasis patients. In line with these findings, CIMT and EFT might be used as reliable diagnostic markers for predicting the future cardiovascular risks and being as an early sign of subclinical atherogenesis in patients with psoriasis. Certain limitations in our study included; relatively small sample size and different protocols for measuring CIMT and EFT such as computed tomography (CT) and magnetic resonance imaging (MRI) that led to variability of the measurements within the studies.
CONCLUSION
Our data concluded that chemerin, leptin and psoriasin might be an important association between psoriasis and atherosclerosis. Screening for plasma chemerin, leptin and psoriasin along with CIMT and EFT as potential markers of subclinical atherosclerosis in psoriasis patients is suggested. CIMT and EFT are simple, non-invasive and reliable methods for predicting risk stratification and subclinical atherosclerosis in psoriasis patients in order to reduce their morbidity and mortality.
